1. Compared to sitagliptin and glimepiride, glargine and liraglutide were more effective in achieving target glycated hemoglobin levels in patients ...
![Type I diabetes not associated with early menopause [OVADIA study]](https://2minutemedicine-wpengine.netdna-ssl.com/wp-content/uploads/2014/12/diabetes1_edited-350x250.jpg)
1. No significant differences in vascular complications of diabetes were seen in patients using metformin and adjunctive glargine, liraglutide, glimepiride, ...
1. At week 16, average neuropathic pain score decreased for all three treatment groups. 2. Pain reduction was greater in ...
1. In patients with diabetic macular edema, aflibercept monotherapy showed no difference in vision improvement compared to step therapy of ...
1. In a retrospective cohort of about 3,000 children and young adults, new diagnoses of type 2 diabetes increased by ...
1. Dulaglutide significantly reduced baseline glycated hemoglobin levels as compared to a placebo control in youth with type 2 diabetes ...
1. In this secondary analysis of the DECLARE-TIMI 58 trial, among 17,160 patients, dapagliflozin consistently reduced the risk of cardiovascular ...
1. In patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT-2i) use was associated with reduced risk of composite ...
1. Previous studies suggest that intensive blood glucose control reduces the risk of microvascular complications, though questions remained regarding the ...
1. In this study, both low and high levels of B12 in serum was associated with higher risk of cardiovascular ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.